Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| CAD19 | Q9H159 | Cadherin-19 | Predicted intracellular proteinsPredicted membrane proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.25 | |||
| CADH9 | Q9ULB4 | Cadherin-9 | Predicted intracellular proteinsPredicted membrane proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.25 | |||
| CAH12 | O43570 | Carbonic anhydrase 12 (EC 4.2.1.1) (Carbonate dehydratase XII) (Carbonic anhydrase XII) (CA-XII) (Tumor antigen HOM-RCC-3.1.3) | Disease related genesEnzymesFDA approved drug targets | 1 | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.25 | |||
| CANT1 | Q8WVQ1 | Soluble calcium-activated nucleotidase 1 (SCAN-1) (EC 3.6.1.6) (Apyrase homolog) (Putative MAPK-activating protein PM09) (Putative NF-kappa-B-activating protein 107) | Cancer-related genesDisease related genesEnzymes | 1 | Immune mediationReceptor-signaling mediation | 1 | 0.25 | |||
| CCG8 | Q8WXS5 | Voltage-dependent calcium channel gamma-8 subunit (Neuronal voltage-gated calcium channel gamma-8 subunit) (Transmembrane AMPAR regulatory protein gamma-8) (TARP gamma-8) | 5 | Fusion and delivery mediation | 1 | 0.25 | ||||
| CCR7 | P32248 | C-C chemokine receptor type 7 (C-C CKR-7) (CC-CKR-7) (CCR-7) (BLR2) (CDw197) (Epstein-Barr virus-induced G-protein coupled receptor 1) (EBI1) (EBV-induced G-protein coupled receptor 1) (MIP-3 beta receptor) (CD antigen CD197) | Cancer-related genesCD markersG-protein coupled receptors | 7 | Malignant haematopoietic neoplasmMature B-cell leukaemia | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.25 | ||
| CD151 | P48509 | CD151 antigen (GP27) (Membrane glycoprotein SFA-1) (Platelet-endothelial tetraspan antigen 3) (PETA-3) (Tetraspanin-24) (Tspan-24) (CD antigen CD151) | Blood group antigen proteinsCD markersDisease related genes | 4 | Adhesion and uptake mediationImmune mediationReceptor-signaling mediation | 1 | 0.25 | |||
| CD166 | Q13740 | CD166 antigen (Activated leukocyte cell adhesion molecule) (CD antigen CD166) | Cancer-related genesCD markersPlasma proteins | 1 | Solid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.25 | ||
| CD1B | P29016 | T-cell surface glycoprotein CD1b (CD antigen CD1b) | CD markersPredicted membrane proteins | 1 | Fusion and delivery mediationImmune mediation | 1 | 0.25 | |||
| CD1C | P29017 | T-cell surface glycoprotein CD1c (CD antigen CD1c) | 1 | Fusion and delivery mediationImmune mediation | 1 | 0.25 | ||||
| CD302 | Q8IX05 | CD302 antigen (C-type lectin BIMLEC) (C-type lectin domain family 13 member A) (DEC205-associated C-type lectin 1) (Type I transmembrane C-type lectin receptor DCL-1) (CD antigen CD302) | 1 | Fusion and delivery mediationImmune mediation | 1 | 0.25 | ||||
| CD69 | Q07108 | Early activation antigen CD69 (Activation inducer molecule) (AIM) (BL-AC/P26) (C-type lectin domain family 2 member C) (EA1) (Early T-cell activation antigen p60) (GP32/28) (Leukocyte surface antigen Leu-23) (MLR-3) (CD antigen CD69) | CD markersPredicted membrane proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | |||
| CD80 | P33681 | T-lymphocyte activation antigen CD80 (Activation B7-1 antigen) (BB1) (CTLA-4 counter-receptor B7.1) (B7) (CD antigen CD80) | CD markersFDA approved drug targetsPredicted intracellular proteins | 1 | Diabetes mellitusLung cancerLymphoma | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.25 | ||
| CDON | Q4KMG0 | Cell adhesion molecule-related/down-regulated by oncogenes | Disease related genesHuman disease related genesPredicted membrane proteins | 1 | Receptor-signaling mediation | 1 | 0.25 | |||
| CEAM1 | P13688 | Cell adhesion molecule CEACAM1 (Biliary glycoprotein 1) (BGP-1) (Carcinoembryonic antigen-related cell adhesion molecule 1) (CEA cell adhesion molecule 1) (CD antigen CD66a) | CD markersPlasma proteinsPredicted intracellular proteins | 1 | Solid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.25 | ||
| CK024 | Q96F05 | Uncharacterized protein C11orf24 (Protein DM4E3) | Predicted intracellular proteinsPredicted membrane proteins | 1 | Other mediation | 1 | 0.25 | |||
| CLCN2 | P51788 | Chloride channel protein 2 (ClC-2) | Disease related genesFDA approved drug targetsHuman disease related genes | 10 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | |||
| CLDN1 | Q9NY35 | Claudin domain-containing protein 1 (Claudin-25) (Membrane protein GENX-3745) | Predicted intracellular proteinsPredicted membrane proteinsTransporters | 4 | Fusion and delivery mediation | 1 | 0.25 | |||
| CLTR1 | Q9Y271 | Cysteinyl leukotriene receptor 1 (CysLTR1) (Cysteinyl leukotriene D4 receptor) (LTD4 receptor) (G-protein coupled receptor HG55) (HMTMF81) | FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins | 7 | Allergic/hypersensitivity disorderAsthmaMigraine | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 1 | 0.25 | ||
| CNTFR | P26992 | Ciliary neurotrophic factor receptor subunit alpha (CNTF receptor subunit alpha) (CNTFR-alpha) | Plasma proteinsPredicted intracellular proteinsPredicted membrane proteins | GlaucomaInherited retinal dystrophyMacular degeneration | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | |||
| CNTN1 | Q12860 | Contactin-1 (Glycoprotein gp135) (Neural cell surface protein F3) | Disease related genesHuman disease related genesPlasma proteins | Fusion and delivery mediationReceptor-signaling mediation | 1 | 0.25 | ||||
| CNTN3 | Q9P232 | Contactin-3 (Brain-derived immunoglobulin superfamily protein 1) (BIG-1) (Plasmacytoma-associated neuronal glycoprotein) | Plasma proteinsPredicted intracellular proteins | Metabolism mediation | 1 | 0.25 | ||||
| CTL2 | Q8IWA5 | Choline transporter-like protein 2 (Solute carrier family 44 member 2) | Metabolic proteinsPredicted intracellular proteinsPredicted membrane proteins | 10 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | |||
| CTL5 | Q8NCS7 | Choline transporter-like protein 5 (Solute carrier family 44 member 5) | Metabolic proteinsPredicted membrane proteinsTransporters | 10 | Fusion and delivery mediationMetabolism mediation | 1 | 0.25 | |||
| CTNS | O60931 | Cystinosin | 7 | Amino acid absorption/transport disorder | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.25 |